A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients
Status:
Completed
Trial end date:
2020-08-21
Target enrollment:
Participant gender:
Summary
The trial is randomized, blinded, two arms, active comparator controlled, clinical trial to
evaluate the safety and efficacy of Mycobacterium w in combination with standard care as per
hospital practice versus standard care alone in critically ill adult patients suffering from
COVID-19 infection.
Phase:
N/A
Details
Lead Sponsor:
Cadila Pharnmaceuticals
Collaborator:
Council of Scientific and Industrial Research, India